Two Sigma Advisers’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,393
Closed -$249K 2596
2025
Q1
$249K Sell
16,393
-5,000
-23% -$76.1K ﹤0.01% 2055
2024
Q4
$393K Sell
21,393
-2,671
-11% -$49K ﹤0.01% 1870
2024
Q3
$267K Buy
24,064
+131
+0.5% +$1.45K ﹤0.01% 1961
2024
Q2
$222K Buy
23,933
+5,602
+31% +$52K ﹤0.01% 2175
2024
Q1
$601K Buy
18,331
+4,048
+28% +$133K ﹤0.01% 1798
2023
Q4
$382K Buy
14,283
+10,466
+274% +$280K ﹤0.01% 2026
2023
Q3
$231K Buy
3,817
+256
+7% +$15.5K ﹤0.01% 2061
2023
Q2
$363K Buy
3,561
+2,842
+395% +$290K ﹤0.01% 1923
2023
Q1
$127K Buy
+719
New +$127K ﹤0.01% 2344
2022
Q3
Sell
-472
Closed -$155K 2766
2022
Q2
$155K Sell
472
-20
-4% -$6.57K ﹤0.01% 2328
2022
Q1
$215K Buy
+492
New +$215K ﹤0.01% 2361
2021
Q4
Sell
-1,892
Closed -$1.05M 2836
2021
Q3
$1.05M Sell
1,892
-5,483
-74% -$3.05M ﹤0.01% 1596
2021
Q2
$3.79M Sell
7,375
-3,117
-30% -$1.6M 0.01% 991
2021
Q1
$8.2M Buy
10,492
+3,073
+41% +$2.4M 0.02% 646
2020
Q4
$4.04M Buy
7,419
+822
+12% +$448K 0.01% 913
2020
Q3
$3.02M Buy
6,597
+3,836
+139% +$1.76M 0.01% 955
2020
Q2
$1.7M Buy
2,761
+2,136
+342% +$1.32M 0.01% 1285
2020
Q1
$297K Buy
625
+42
+7% +$20K ﹤0.01% 2016
2019
Q4
$338K Buy
583
+191
+49% +$111K ﹤0.01% 2022
2019
Q3
$258K Buy
+392
New +$258K ﹤0.01% 1971
2019
Q2
Sell
-1,036
Closed -$732K 2470
2019
Q1
$732K Sell
1,036
-64
-6% -$45.2K ﹤0.01% 1641
2018
Q4
$515K Buy
1,100
+575
+110% +$269K ﹤0.01% 1758
2018
Q3
$453K Buy
+525
New +$453K ﹤0.01% 1833
2018
Q1
Sell
-450
Closed -$198K 2442
2017
Q4
$198K Sell
450
-25
-5% -$11K ﹤0.01% 2089
2017
Q3
$234K Buy
475
+86
+22% +$42.4K ﹤0.01% 2007
2017
Q2
$215K Buy
+389
New +$215K ﹤0.01% 2099
2016
Q2
Sell
-411
Closed -$92K 2221
2016
Q1
$92K Buy
+411
New +$92K ﹤0.01% 1946
2015
Q4
Sell
-519
Closed -$273K 2049
2015
Q3
$273K Buy
+519
New +$273K ﹤0.01% 1537